Company / Operating Income
VitaNova Life Sciences Corp Operating Income History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$1.2M
FY2024
5-year range
-$24.2K / $1.2M
FY2020-FY2024
Trend
+487.6%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income changed +488% YoY in FY2024, a notable deviation from the 6-year average annual change of +243%.
Based on SEC 10-K filings.
$1M in FY2024.
Improved from -$24,227 to $1M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2024, operating income increased 487.6% year-over-year.
- Lowest operating income in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 3.24 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $1.2M | +487.6% |
| FY2023 | $205.6K | +948.8% |
| FY2022 | -$24.2K | -81.2% |
| FY2021 | -$13.4K | +74.3% |
| FY2020 | -$52.1K | +28.0% |
| FY2019 | -$72.3K | -0.7% |
| FY2018 | -$71.8K | - |
As of FY2024 · SEC 10-K · Updated Jun 29, 2026